nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLCO2B1—Montelukast—chronic obstructive pulmonary disease	0.26	0.451	CbGbCtD
Niacin—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.179	0.309	CbGbCtD
Niacin—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.048	0.083	CbGbCtD
Niacin—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.048	0.083	CbGbCtD
Niacin—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0428	0.074	CbGbCtD
Niacin—HCAR2—respiratory system—chronic obstructive pulmonary disease	0.0105	0.121	CbGeAlD
Niacin—HCAR2—connective tissue—chronic obstructive pulmonary disease	0.00927	0.107	CbGeAlD
Niacin—HCAR3—lung—chronic obstructive pulmonary disease	0.00845	0.0973	CbGeAlD
Niacin—NNMT—respiratory system—chronic obstructive pulmonary disease	0.00593	0.0682	CbGeAlD
Niacin—HCAR2—lung—chronic obstructive pulmonary disease	0.00559	0.0644	CbGeAlD
Niacin—NNMT—connective tissue—chronic obstructive pulmonary disease	0.00522	0.0601	CbGeAlD
Niacin—NNMT—bronchus—chronic obstructive pulmonary disease	0.00488	0.0562	CbGeAlD
Niacin—NNMT—smooth muscle tissue—chronic obstructive pulmonary disease	0.00477	0.055	CbGeAlD
Niacin—NNMT—trachea—chronic obstructive pulmonary disease	0.00438	0.0504	CbGeAlD
Niacin—SLC16A3—respiratory system—chronic obstructive pulmonary disease	0.00405	0.0466	CbGeAlD
Niacin—SLC16A3—bronchus—chronic obstructive pulmonary disease	0.00333	0.0384	CbGeAlD
Niacin—SLC16A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00326	0.0375	CbGeAlD
Niacin—NNMT—lung—chronic obstructive pulmonary disease	0.00315	0.0362	CbGeAlD
Niacin—SLC16A3—trachea—chronic obstructive pulmonary disease	0.00299	0.0345	CbGeAlD
Niacin—SLC16A3—lung—chronic obstructive pulmonary disease	0.00215	0.0248	CbGeAlD
Niacin—SLCO2B1—respiratory system—chronic obstructive pulmonary disease	0.00212	0.0244	CbGeAlD
Niacin—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.0014	0.0162	CbGeAlD
Niacin—SLC16A1—lung—chronic obstructive pulmonary disease	0.00131	0.015	CbGeAlD
Niacin—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.00116	0.0133	CbGeAlD
Niacin—SLCO2B1—lung—chronic obstructive pulmonary disease	0.00112	0.0129	CbGeAlD
Niacin—SLC22A5—trachea—chronic obstructive pulmonary disease	0.00104	0.012	CbGeAlD
Niacin—SLC22A5—lung—chronic obstructive pulmonary disease	0.000746	0.00859	CbGeAlD
Niacin—QPRT—Metabolism—APIP—chronic obstructive pulmonary disease	0.000746	0.00656	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000727	0.0064	CbGpPWpGaD
Niacin—NNMT—Metabolism—APIP—chronic obstructive pulmonary disease	0.000693	0.0061	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00069	0.00606	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000663	0.00583	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000633	0.00556	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000599	0.00527	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000596	0.00524	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—MMP1—chronic obstructive pulmonary disease	0.000587	0.00516	CbGpPWpGaD
Niacin—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000582	0.00512	CbGpPWpGaD
Niacin—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000582	0.00512	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000568	0.005	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000565	0.00497	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000553	0.00486	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000539	0.00474	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000535	0.00471	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000518	0.00456	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00051	0.00448	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000508	0.00446	CbGpPWpGaD
Niacin—QPRT—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000494	0.00434	CbGpPWpGaD
Niacin—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000487	0.00428	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000483	0.00425	CbGpPWpGaD
Niacin—QPRT—Metabolism—GC—chronic obstructive pulmonary disease	0.00048	0.00422	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00048	0.00422	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000479	0.00421	CbGpPWpGaD
Niacin—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000469	0.00412	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000468	0.00412	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000463	0.00407	CbGpPWpGaD
Niacin—NNMT—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000459	0.00404	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000456	0.00401	CbGpPWpGaD
Niacin—NNMT—Metabolism—GC—chronic obstructive pulmonary disease	0.000447	0.00393	CbGpPWpGaD
Niacin—QPRT—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000447	0.00393	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000444	0.0039	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000439	0.00386	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000433	0.0038	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000427	0.00375	CbGpPWpGaD
Niacin—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000423	0.00372	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000422	0.00371	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000421	0.0037	CbGpPWpGaD
Niacin—NNMT—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000415	0.00365	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000412	0.00362	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000411	0.00361	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000408	0.00359	CbGpPWpGaD
Niacin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00178	CcSEcCtD
Niacin—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00177	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00039	0.00343	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00039	0.00176	CcSEcCtD
Niacin—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00175	CcSEcCtD
Niacin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000387	0.00175	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000387	0.0034	CbGpPWpGaD
Niacin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00174	CcSEcCtD
Niacin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00174	CcSEcCtD
Niacin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000384	0.00173	CcSEcCtD
Niacin—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00173	CcSEcCtD
Niacin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00171	CcSEcCtD
Niacin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000376	0.0017	CcSEcCtD
Niacin—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00169	CcSEcCtD
Niacin—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00169	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000373	0.00328	CbGpPWpGaD
Niacin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000371	0.00167	CcSEcCtD
Niacin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00167	CcSEcCtD
Niacin—Cough—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00167	CcSEcCtD
Niacin—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00167	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000367	0.00323	CbGpPWpGaD
Niacin—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00165	CcSEcCtD
Niacin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00165	CcSEcCtD
Niacin—HCAR2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000364	0.0032	CbGpPWpGaD
Niacin—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000363	0.00164	CcSEcCtD
Niacin—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000362	0.00318	CbGpPWpGaD
Niacin—Cough—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00163	CcSEcCtD
Niacin—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00163	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000361	0.00317	CbGpPWpGaD
Niacin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.00163	CcSEcCtD
Niacin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.00163	CcSEcCtD
Niacin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.00163	CcSEcCtD
Niacin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00036	0.00163	CcSEcCtD
Niacin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00036	0.00163	CcSEcCtD
Niacin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00162	CcSEcCtD
Niacin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00162	CcSEcCtD
Niacin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00162	CcSEcCtD
Niacin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00162	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00161	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00161	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000357	0.00314	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000356	0.00313	CbGpPWpGaD
Niacin—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000354	0.00311	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000354	0.00311	CbGpPWpGaD
Niacin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00159	CcSEcCtD
Niacin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00159	CcSEcCtD
Niacin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00159	CcSEcCtD
Niacin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00159	CcSEcCtD
Niacin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00159	CcSEcCtD
Niacin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00158	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00158	CcSEcCtD
Niacin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.00158	CcSEcCtD
Niacin—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.00157	CcSEcCtD
Niacin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00157	CcSEcCtD
Niacin—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000348	0.00157	CcSEcCtD
Niacin—HCAR3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000345	0.00303	CbGpPWpGaD
Niacin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00156	CcSEcCtD
Niacin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00156	CcSEcCtD
Niacin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00156	CcSEcCtD
Niacin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00156	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000342	0.00301	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000342	0.003	CbGpPWpGaD
Niacin—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00034	0.00299	CbGpPWpGaD
Niacin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00153	CcSEcCtD
Niacin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00153	CcSEcCtD
Niacin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.00153	CcSEcCtD
Niacin—SLC16A3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000339	0.00298	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000338	0.00297	CbGpPWpGaD
Niacin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000338	0.00153	CcSEcCtD
Niacin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00153	CcSEcCtD
Niacin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00153	CcSEcCtD
Niacin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.00152	CcSEcCtD
Niacin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000337	0.00152	CcSEcCtD
Niacin—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000335	0.00151	CcSEcCtD
Niacin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00151	CcSEcCtD
Niacin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00151	CcSEcCtD
Niacin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000334	0.00151	CcSEcCtD
Niacin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.0015	CcSEcCtD
Niacin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.00149	CcSEcCtD
Niacin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000328	0.00148	CcSEcCtD
Niacin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00147	CcSEcCtD
Niacin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00147	CcSEcCtD
Niacin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00146	CcSEcCtD
Niacin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00146	CcSEcCtD
Niacin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000321	0.00145	CcSEcCtD
Niacin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00145	CcSEcCtD
Niacin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00144	CcSEcCtD
Niacin—SLC16A3—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000318	0.00279	CbGpPWpGaD
Niacin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000318	0.00143	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—MMP1—chronic obstructive pulmonary disease	0.000317	0.00279	CbGpPWpGaD
Niacin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00143	CcSEcCtD
Niacin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000315	0.00142	CcSEcCtD
Niacin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00142	CcSEcCtD
Niacin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.00142	CcSEcCtD
Niacin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000314	0.00142	CcSEcCtD
Niacin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00141	CcSEcCtD
Niacin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00141	CcSEcCtD
Niacin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.0014	CcSEcCtD
Niacin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.0014	CcSEcCtD
Niacin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000308	0.00139	CcSEcCtD
Niacin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000308	0.00139	CcSEcCtD
Niacin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.00139	CcSEcCtD
Niacin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00139	CcSEcCtD
Niacin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00139	CcSEcCtD
Niacin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000306	0.00138	CcSEcCtD
Niacin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00137	CcSEcCtD
Niacin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00137	CcSEcCtD
Niacin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00137	CcSEcCtD
Niacin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00137	CcSEcCtD
Niacin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000302	0.00137	CcSEcCtD
Niacin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00136	CcSEcCtD
Niacin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0003	0.00135	CcSEcCtD
Niacin—SLC16A1—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000299	0.00263	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00135	CcSEcCtD
Niacin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00135	CcSEcCtD
Niacin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00134	CcSEcCtD
Niacin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00134	CcSEcCtD
Niacin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000295	0.00133	CcSEcCtD
Niacin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.00133	CcSEcCtD
Niacin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00133	CcSEcCtD
Niacin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00132	CcSEcCtD
Niacin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00132	CcSEcCtD
Niacin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00131	CcSEcCtD
Niacin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00131	CcSEcCtD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000289	0.00254	CbGpPWpGaD
Niacin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000289	0.00131	CcSEcCtD
Niacin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.0013	CcSEcCtD
Niacin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.0013	CcSEcCtD
Niacin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.00129	CcSEcCtD
Niacin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.00129	CcSEcCtD
Niacin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.00128	CcSEcCtD
Niacin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00128	CcSEcCtD
Niacin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000283	0.00128	CcSEcCtD
Niacin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00127	CcSEcCtD
Niacin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00127	CcSEcCtD
Niacin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00127	CcSEcCtD
Niacin—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000281	0.00247	CbGpPWpGaD
Niacin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00126	CcSEcCtD
Niacin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00125	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000276	0.00125	CcSEcCtD
Niacin—SLC16A3—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000275	0.00242	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000274	0.00241	CbGpPWpGaD
Niacin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00124	CcSEcCtD
Niacin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00124	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000274	0.00241	CbGpPWpGaD
Niacin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00123	CcSEcCtD
Niacin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00123	CcSEcCtD
Niacin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00123	CcSEcCtD
Niacin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00123	CcSEcCtD
Niacin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.00123	CcSEcCtD
Niacin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00122	CcSEcCtD
Niacin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00122	CcSEcCtD
Niacin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00122	CcSEcCtD
Niacin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00121	CcSEcCtD
Niacin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00121	CcSEcCtD
Niacin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00121	CcSEcCtD
Niacin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00121	CcSEcCtD
Niacin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000267	0.0012	CcSEcCtD
Niacin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.0012	CcSEcCtD
Niacin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.00119	CcSEcCtD
Niacin—QPRT—Disease—HDAC2—chronic obstructive pulmonary disease	0.000263	0.00232	CbGpPWpGaD
Niacin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00119	CcSEcCtD
Niacin—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000263	0.00231	CbGpPWpGaD
Niacin—QPRT—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000262	0.00231	CbGpPWpGaD
Niacin—QPRT—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000259	0.00228	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000259	0.00228	CbGpPWpGaD
Niacin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00117	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000258	0.00227	CbGpPWpGaD
Niacin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00116	CcSEcCtD
Niacin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00116	CcSEcCtD
Niacin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00115	CcSEcCtD
Niacin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00115	CcSEcCtD
Niacin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00115	CcSEcCtD
Niacin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00114	CcSEcCtD
Niacin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00114	CcSEcCtD
Niacin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00112	CcSEcCtD
Niacin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00112	CcSEcCtD
Niacin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00112	CcSEcCtD
Niacin—SLC16A3—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000247	0.00217	CbGpPWpGaD
Niacin—QPRT—Disease—KL—chronic obstructive pulmonary disease	0.000245	0.00215	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000244	0.00215	CbGpPWpGaD
Niacin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000244	0.0011	CcSEcCtD
Niacin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.0011	CcSEcCtD
Niacin—NNMT—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000244	0.00215	CbGpPWpGaD
Niacin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000244	0.0011	CcSEcCtD
Niacin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00109	CcSEcCtD
Niacin—NNMT—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000241	0.00212	CbGpPWpGaD
Niacin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00109	CcSEcCtD
Niacin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00108	CcSEcCtD
Niacin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00108	CcSEcCtD
Niacin—QPRT—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000237	0.00208	CbGpPWpGaD
Niacin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00107	CcSEcCtD
Niacin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00107	CcSEcCtD
Niacin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.00106	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000234	0.00206	CbGpPWpGaD
Niacin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00106	CcSEcCtD
Niacin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00104	CcSEcCtD
Niacin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00104	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00023	0.00203	CbGpPWpGaD
Niacin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00103	CcSEcCtD
Niacin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00103	CcSEcCtD
Niacin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00103	CcSEcCtD
Niacin—SLC16A3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000224	0.00197	CbGpPWpGaD
Niacin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00101	CcSEcCtD
Niacin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00101	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000223	0.00196	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000222	0.00195	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000221	0.00194	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00022	0.00194	CbGpPWpGaD
Niacin—NNMT—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00022	0.00194	CbGpPWpGaD
Niacin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000993	CcSEcCtD
Niacin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.000991	CcSEcCtD
Niacin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000219	0.000991	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000218	0.00192	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GC—chronic obstructive pulmonary disease	0.000218	0.00192	CbGpPWpGaD
Niacin—QPRT—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000218	0.00192	CbGpPWpGaD
Niacin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000218	0.000982	CcSEcCtD
Niacin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.000982	CcSEcCtD
Niacin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000981	CcSEcCtD
Niacin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000981	CcSEcCtD
Niacin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.000976	CcSEcCtD
Niacin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000216	0.000976	CcSEcCtD
Niacin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000974	CcSEcCtD
Niacin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.000973	CcSEcCtD
Niacin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00097	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000214	0.00188	CbGpPWpGaD
Niacin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000962	CcSEcCtD
Niacin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000961	CcSEcCtD
Niacin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000212	0.000956	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000209	0.00184	CbGpPWpGaD
Niacin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000945	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000209	0.00184	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000209	0.00184	CbGpPWpGaD
Niacin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.000935	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000207	0.00182	CbGpPWpGaD
Niacin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000929	CcSEcCtD
Niacin—SLC16A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000206	0.00181	CbGpPWpGaD
Niacin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000928	CcSEcCtD
Niacin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000927	CcSEcCtD
Niacin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000927	CcSEcCtD
Niacin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.000925	CcSEcCtD
Niacin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000205	0.000925	CcSEcCtD
Niacin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000922	CcSEcCtD
Niacin—NNMT—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.00178	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000203	0.00178	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.00178	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000202	0.00177	CbGpPWpGaD
Niacin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000909	CcSEcCtD
Niacin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000201	0.000907	CcSEcCtD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.0002	0.00176	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000198	0.00174	CbGpPWpGaD
Niacin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.000874	CcSEcCtD
Niacin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000867	CcSEcCtD
Niacin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000863	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000191	0.00168	CbGpPWpGaD
Niacin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000844	CcSEcCtD
Niacin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000844	CcSEcCtD
Niacin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00083	CcSEcCtD
Niacin—QPRT—Disease—ERBB3—chronic obstructive pulmonary disease	0.000184	0.00161	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000183	0.00161	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000183	0.00161	CbGpPWpGaD
Niacin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000824	CcSEcCtD
Niacin—QPRT—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000182	0.0016	CbGpPWpGaD
Niacin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000816	CcSEcCtD
Niacin—QPRT—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000179	0.00158	CbGpPWpGaD
Niacin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000807	CcSEcCtD
Niacin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000801	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000174	0.00153	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000174	0.00153	CbGpPWpGaD
Niacin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000783	CcSEcCtD
Niacin—SLC16A1—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000172	0.00151	CbGpPWpGaD
Niacin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000771	CcSEcCtD
Niacin—NNMT—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000169	0.00149	CbGpPWpGaD
Niacin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000763	CcSEcCtD
Niacin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000763	CcSEcCtD
Niacin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000758	CcSEcCtD
Niacin—QPRT—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000167	0.00147	CbGpPWpGaD
Niacin—NNMT—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000167	0.00147	CbGpPWpGaD
Niacin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000751	CcSEcCtD
Niacin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000751	CcSEcCtD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.00144	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000161	0.00142	CbGpPWpGaD
Niacin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000722	CcSEcCtD
Niacin—SLC16A3—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000159	0.0014	CbGpPWpGaD
Niacin—QPRT—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00139	CbGpPWpGaD
Niacin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000708	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000156	0.00137	CbGpPWpGaD
Niacin—NNMT—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000155	0.00137	CbGpPWpGaD
Niacin—QPRT—Disease—NOS2—chronic obstructive pulmonary disease	0.000153	0.00135	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000153	0.00134	CbGpPWpGaD
Niacin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000687	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00015	0.00132	CbGpPWpGaD
Niacin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000675	CcSEcCtD
Niacin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000674	CcSEcCtD
Niacin—SLC16A1—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000149	0.00131	CbGpPWpGaD
Niacin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00067	CcSEcCtD
Niacin—NNMT—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.0013	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00129	CbGpPWpGaD
Niacin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00066	CcSEcCtD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00128	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000144	0.00126	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000142	0.00125	CbGpPWpGaD
Niacin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00064	CcSEcCtD
Niacin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00064	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000635	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000138	0.00122	CbGpPWpGaD
Niacin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000622	CcSEcCtD
Niacin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000613	CcSEcCtD
Niacin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000613	CcSEcCtD
Niacin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000603	CcSEcCtD
Niacin—SLC16A1—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000133	0.00117	CbGpPWpGaD
Niacin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000598	CcSEcCtD
Niacin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000596	CcSEcCtD
Niacin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000593	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000131	0.00115	CbGpPWpGaD
Niacin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000584	CcSEcCtD
Niacin—QPRT—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000129	0.00113	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000125	0.0011	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000125	0.0011	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000559	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000124	0.00109	CbGpPWpGaD
Niacin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000558	CcSEcCtD
Niacin—QPRT—Disease—NOS3—chronic obstructive pulmonary disease	0.000123	0.00108	CbGpPWpGaD
Niacin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000555	CcSEcCtD
Niacin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000551	CcSEcCtD
Niacin—SLC16A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000121	0.00106	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000121	0.00106	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000121	0.00106	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.00012	0.00106	CbGpPWpGaD
Niacin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00054	CcSEcCtD
Niacin—SLC16A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000119	0.00105	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00105	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000118	0.00104	CbGpPWpGaD
Niacin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000533	CcSEcCtD
Niacin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000532	CcSEcCtD
Niacin—SLC16A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000118	0.00104	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000118	0.00104	CbGpPWpGaD
Niacin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000532	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000117	0.00103	CbGpPWpGaD
Niacin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000529	CcSEcCtD
Niacin—SLC16A3—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000115	0.00101	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000113	0.000994	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000112	0.000988	CbGpPWpGaD
Niacin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000501	CcSEcCtD
Niacin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000501	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000111	0.000976	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00011	0.000963	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000108	0.000951	CbGpPWpGaD
Niacin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000487	CcSEcCtD
Niacin—QPRT—Metabolism—ALB—chronic obstructive pulmonary disease	0.000108	0.000947	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000107	0.000945	CbGpPWpGaD
Niacin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000485	CcSEcCtD
Niacin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000485	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000107	0.000943	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000107	0.000937	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000106	0.00093	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000105	0.000922	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000104	0.000918	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000104	0.000911	CbGpPWpGaD
Niacin—QPRT—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000103	0.000906	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000103	0.000901	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000101	0.000884	CbGpPWpGaD
Niacin—NNMT—Metabolism—ALB—chronic obstructive pulmonary disease	0.0001	0.000881	CbGpPWpGaD
Niacin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000452	CcSEcCtD
Niacin—SLC16A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.9e-05	0.000871	CbGpPWpGaD
Niacin—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.00044	CcSEcCtD
Niacin—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.000434	CcSEcCtD
Niacin—NNMT—Metabolism—NOS3—chronic obstructive pulmonary disease	9.58e-05	0.000842	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	9.54e-05	0.000839	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.53e-05	0.000838	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.39e-05	0.000826	CbGpPWpGaD
Niacin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.00042	CcSEcCtD
Niacin—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.98e-05	0.000405	CcSEcCtD
Niacin—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.71e-05	0.000766	CbGpPWpGaD
Niacin—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.00039	CcSEcCtD
Niacin—SLC16A1—Hemostasis—MMP1—chronic obstructive pulmonary disease	8.6e-05	0.000756	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.59e-05	0.000755	CbGpPWpGaD
Niacin—Rash—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000387	CcSEcCtD
Niacin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.55e-05	0.000386	CcSEcCtD
Niacin—Headache—Prednisone—chronic obstructive pulmonary disease	8.51e-05	0.000384	CcSEcCtD
Niacin—SLC16A1—Hemostasis—PLAU—chronic obstructive pulmonary disease	8.44e-05	0.000742	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.31e-05	0.000731	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.27e-05	0.000727	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.26e-05	0.000726	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.15e-05	0.000716	CbGpPWpGaD
Niacin—QPRT—Disease—TGFB1—chronic obstructive pulmonary disease	8.14e-05	0.000715	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.08e-05	0.00071	CbGpPWpGaD
Niacin—Nausea—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000364	CcSEcCtD
Niacin—QPRT—Disease—EGFR—chronic obstructive pulmonary disease	7.98e-05	0.000702	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.89e-05	0.000694	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.84e-05	0.000689	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS2—chronic obstructive pulmonary disease	7.75e-05	0.000682	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.63e-05	0.000671	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.59e-05	0.000667	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.53e-05	0.000662	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.48e-05	0.000658	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.27e-05	0.000639	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.2e-05	0.000633	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.17e-05	0.00063	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.14e-05	0.000628	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.68e-05	0.000587	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.68e-05	0.000587	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.59e-05	0.000579	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	6.53e-05	0.000574	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—chronic obstructive pulmonary disease	6.51e-05	0.000573	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.44e-05	0.000566	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.36e-05	0.000559	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.35e-05	0.000559	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.35e-05	0.000558	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.33e-05	0.000557	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.33e-05	0.000557	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—chronic obstructive pulmonary disease	6.28e-05	0.000552	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.24e-05	0.000549	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS3—chronic obstructive pulmonary disease	6.23e-05	0.000548	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—chronic obstructive pulmonary disease	6.13e-05	0.000539	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.04e-05	0.000531	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.02e-05	0.00053	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.8e-05	0.00051	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.73e-05	0.000504	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.64e-05	0.000496	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.43e-05	0.000477	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.35e-05	0.00047	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.14e-05	0.000452	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.09e-05	0.000448	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.98e-05	0.000438	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—chronic obstructive pulmonary disease	4.89e-05	0.00043	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.88e-05	0.000429	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.85e-05	0.000426	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.72e-05	0.000415	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.68e-05	0.000411	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.63e-05	0.000407	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.49e-05	0.000395	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.46e-05	0.000392	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.4e-05	0.000387	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.12e-05	0.000362	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.1e-05	0.000361	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.1e-05	0.00036	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.89e-05	0.000342	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.89e-05	0.000342	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.75e-05	0.00033	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.56e-05	0.000313	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—chronic obstructive pulmonary disease	3.39e-05	0.000298	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.37e-05	0.000297	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.28e-05	0.000289	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.05e-05	0.000268	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.64e-05	0.000232	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.53e-05	0.000222	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.79e-05	0.000158	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.77e-05	0.000156	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.62e-05	0.000142	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.49e-05	0.000131	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.24e-05	0.000109	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.000108	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.14e-05	0.0001	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	9.52e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	7.36e-06	6.47e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.04e-06	6.19e-05	CbGpPWpGaD
